Gene · 4175
Papers2,153
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,153
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MCM10: An effective treatment target and a prognostic biomarker in patients with uterine corpus endometrial carcinoma. | J Cell Mol Med | 2023 | 37246638 | PubTator, text mining | PubMed |
| Identification, characterization, and prognosis investigation of pivotal genes shared in different stages of breast cancer. | Sci Rep | 2023 | 37231064 | PubTator, text mining | PubMed |
| Key elements of cellular senescence involve transcriptional repression of mitotic and DNA repair genes through the p53-p16/RB-E2F-DREAM complex. | Aging (Albany NY) | 2023 | 37219418 | PubTator, text mining | PubMed |
| Pinostrobin, a fingerroot compound, regulates miR-181b-5p and induces acute leukemic cell apoptosis. | Sci Rep | 2023 | 37208425 | PubTator, text mining | PubMed |
| De novo MCM6 variants in neurodevelopmental disorders: a recognizable phenotype related to zinc binding residues. | Hum Genet | 2023 | 37198333 | Swiss-Prot, curated | PubMed |
| A DNA-PK phosphorylation site on MET regulates its signaling interface with the DNA damage response. | Oncogene | 2023 | 37188738 | PubTator, text mining | PubMed |
| Socioeconomic Disparities Across the Spectrum of Genetic Burden in Type 2 Diabetes and Obesity Risk. | Diabetes Care | 2023 | 37185692 | PubTator, text mining | PubMed |
| MCM6 promotes intrahepatic cholangiocarcinoma progression by upregulating E2F1 and enhancing epithelial-mesenchymal transition. | Carcinogenesis | 2023 | 37185675 | PubTator, text mining | PubMed |
| Natural compounds ursolic acid and digoxin exhibit inhibitory activities to cancer cells in RORγ-dependent and -independent manner. | Front Pharmacol | 2023 | 37180705 | PubTator, text mining | PubMed |
| Identification of Protein Complexes by Integrating Protein Abundance and Interaction Features Using a Deep Learning Strategy. | Int J Mol Sci | 2023 | 37175590 | PubTator, text mining | PubMed |
| The assembly of the MCM2-7 hetero-hexamer and its significance in DNA replication. | Biochem Soc Trans | 2023 | 37145026 | PubTator, text mining | PubMed |
| Replisome dysfunction upon inducible TIMELESS degradation synergizes with ATR inhibition to trigger replication catastrophe. | Nucleic Acids Res | 2023 | 37144518 | PubTator, text mining | PubMed |
| Expression profiles of east-west highly differentiated genes in Uyghur genomes. | Natl Sci Rev | 2023 | 37138773 | PubTator, text mining | PubMed |
| Bromodomain protein BRD8 regulates cell cycle progression in colorectal cancer cells through a TIP60-independent regulation of the pre-RC complex. | iScience | 2023 | 37123243 | PubTator, text mining | PubMed |
| Human Genes Involved in the Interaction between Host and Gut Microbiome: Regulation and Pathogenic Mechanisms. | Genes (Basel) | 2023 | 37107615 | PubTator, text mining | PubMed |
| Secretome Screening of BRAFV600E-Mutated Colon Cancer Cells Resistant to Vemurafenib. | Biology (Basel) | 2023 | 37106808 | PubTator, text mining | PubMed |
| Integrated analysis of circulating cell free nucleic acids for cancer genotyping and immune phenotyping of tumor microenvironment. | Front Genet | 2023 | 37091783 | PubTator, text mining | PubMed |
| MYC-targeted genes predict distant recurrence in patients with ocular adnexal extranodal marginal zone lymphoma. | Ann Hematol | 2023 | 37083957 | PubTator, text mining | PubMed |
| Identification of p53-target genes in human papillomavirus-associated head and neck cancer by integrative bioinformatics analysis. | Front Oncol | 2023 | 37081989 | PubTator, text mining | PubMed |
| AURKB Enhances Chromosomal Remodeling of Telomeric Genes and Accelerates Tumorigenesis of Uveal Melanoma. | Invest Ophthalmol Vis Sci | 2023 | 37079315 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4175/papers?page=10